The chronic use of beta‐blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|35|2|362-369

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.2, 2015-02, pp. : 362-369

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Beta‐blockers in patients with cirrhosis and infections: don't blame too soon!

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 6, 2015-06 ,pp. : 1778-1779

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: proton pump inhibitors in cirrhosis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 6, 2015-03 ,pp. : 592-592

John Wiley & Sons Inc

Access to resources Recommend Favorite

Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites

By  

HEPATOLOGY, Vol. 64, Iss. 4, 2016-10 ,pp. : 1265-1272

John Wiley & Sons Inc

Access to resources Recommend Favorite

Proton pump inhibitors and cirrhosis

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 1, 2015-01 ,pp. : 147-154

John Wiley & Sons Inc

Access to resources Recommend Favorite

Raised sympathetic activity and blood ammonia could increase sensitivity to infections in patients with cirrhosis and refractory ascites who are using beta‐blockers

By  

HEPATOLOGY, Vol. 54, Iss. 4, 2011-10 ,pp. : 1486-1487

John Wiley & Sons Inc

Access to resources Recommend Favorite